Scarica l'app Stockscreener
0.4575
3.46%
0.0153
Precedente Chiudi:
$0.4422
Aprire:
$0.4477
Volume 24 ore:
133.64K
Relative Volume:
0.68
Capitalizzazione di mercato:
$7.82M
Reddito:
$4.03M
Utile/perdita netta:
$24.32M
Rapporto P/E:
-0.1064
EPS:
-4.3008
Flusso di cassa netto:
$-45.76M
1 W Prestazione:
-1.44%
1M Prestazione:
-23.41%
6M Prestazione:
-30.58%
1 anno Prestazione:
-38.18%
Intervallo 1D:
$0.44
$0.47
Intervallo di 1 settimana:
$0.304
$0.48
Portata 52W:
$0.304
$1.90
Pavmed Inc Stock (PAVM) Company Profile
Nome
Pavmed Inc
Settore
Industria
Telefono
(212) 949-4319
Indirizzo
360 MADISON AVENUE, NEW YORK, NY
Confronta PAVM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.4575 | 7.78M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
129.07 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.82 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.61 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.99 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.75 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Iniziato | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Iniziato | Maxim Group | Buy |
Pavmed Inc Borsa (PAVM) Ultime notizie
Transcript : PAVmed Inc., Lucid Diagnostics Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
Earnings call transcript: Lucid Diagnostics highlights Q2 2025 growth and Medicare focus - Investing.com India
Lucid Diagnostics Advances Towards Medicare Coverage - TipRanks
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - Morningstar
What makes PAVmed Inc. stock price move sharplyShort-Term Explosive Growth - thegnnews.com
PAVmed's Q2 2025 Earnings: A Strategic Inflection Point in Healthcare Innovation and Financial Turnaround - AInvest
PAVmed PAVM 2025Q2 Earnings Preview Upside Potential Driven by Strategic Innovations - AInvest
Lucid Diagnostics to Participate in Upcoming Investor Conferences - Eastern Progress
Published on: 2025-08-05 15:46:56 - metal.it
Trendline Breach Raises Concern for PAVmed Inc. InvestorsTriple Return Setup With Risk Control Explained - metal.it
PAVmed Inc. Forms Bullish Flag — Upside AheadEntry Plan for Oversold Reversal Stocks Released - metal.it
PAVmed Inc. Crosses 200 Day MA — Signal or NoiseReal-Time Analysis With Entry Targets In Progress - metal.it
Is PAVmed Inc. a growth stock or a value stockHigh-velocity gains - Jammu Links News
What are analysts’ price targets for PAVmed Inc. in the next 12 monthsUnlock exclusive stock analysis for investors - Jammu Links News
What analysts say about PAVmed Inc. stockUnlock powerful trading alerts for success - Jammu Links News
What are the latest earnings results for PAVmed Inc.Free Stock Selection - Jammu Links News
Does PAVmed Inc. stock perform well during market downturnsTrack high-yield stocks before they peak - Jammu Links News
When is PAVmed Inc. stock expected to show significant growthTremendous portfolio expansion - Jammu Links News
How strong is PAVmed Inc. company’s balance sheetCapitalize on emerging market sectors - Jammu Links News
What markets is BHST expanding into Is PAVmed Inc. stock a good long term investment option - Jammu Links News
Nasdaq Grants PAVmed 180-Day Extension to Meet Minimum Bid Price Rule - AInvest
Pavmed Inc. shares fall 1.22% after-hours following announcement of a business update conference call. - AInvest
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
PAVmed to Host Business Update Conference Call on August 14, 2025. - AInvest
PAVmed CEO and CFO to Present Q2 2025 Results and Growth Strategy Update on August 14 - Stock Titan
Pattern recognition hints at PAVmed Inc. upsideCommunity Shared Smart Money Signals Show Movement - metal.it
Lucid Diagnostics to Host Business Update Conference Call and Webcast on August 13, 2025 - AInvest
Should I hold or sell PAVmed Inc. stock in 2025Advanced Screener Ideas For Fast Growth - Jammu Links News
Why PAVmed Inc. stock attracts strong analyst attentionGrowth Based Investment Plan Guidance Highlighted - beatles.ru
Real Time Chart Alerts Flash Bullish on PAVmed Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru
PAVmed granted 180-day extension to meet Nasdaq minimum bid price - Investing.com Nigeria
PAVmed Granted Nasdaq Extension for Compliance - TipRanks
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - WV News
PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PR Newswire
Cancer Prevention Leader Lucid Diagnostics to Reveal Q2 2025 Financial Results and Growth Strategy - Stock Titan
Published on: 2025-07-29 22:46:56 - metal.it
RSI Reset May Fuel Rebound in PAVmed Inc.AI Powered High Return Stock Calls Dominate Watchlists - metal.it
How did PAVM's revenue and expenses trend in Q4 2024? - AInvest
What is the dividend policy of PAVmed Inc. stockSmart Portfolio Signals To Watch Now - Jammu Links News
What institutional investors are buying PAVmed Inc. stockRapidly growing investment returns - Jammu Links News
Pavmed Inc Azioni (PAVM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.18%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):